Prognostic factors in drug-coated balloon interventions for treating the side branch of coronary bifurcation lesions. [PDF]
Valencia J +5 more
europepmc +1 more source
Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis. [PDF]
Padilla L +12 more
europepmc +1 more source
Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trials. [PDF]
Sorolla Romero JA +11 more
europepmc +1 more source
Resúmenes presentados al 36 Congreso de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología. Santiago de Compostela, 4-6 de junio de 2025. [PDF]
europepmc +1 more source
[Detrimental impact of acute coronary syndrome on the independence of the elderly]. [PDF]
Coello P +4 more
europepmc +1 more source
Sirolimus-coated balloon in young versus old patients with coronary artery disease: a sub-analysis of the EASTBOURNE study. [PDF]
Luca Gurgoglione F +4 more
europepmc +1 more source
Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial. [PDF]
Gómez-Lara J +34 more
europepmc +1 more source
Debate. "Orbiting" around the management of stable angina. The interventional cardiologist's perspective. [PDF]
Martín Moreiras J.
europepmc +1 more source
Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis. [PDF]
Padilla L, Tello J, Lamelas P.
europepmc +1 more source
Recommendations for the management of ST-elevation myocardial infarction after reperfusion. [PDF]
Britto FW.
europepmc +1 more source

